{
  "description": "This contains a list of OFI Special Cases.",
  "_filename": "cs-OFI-SPECIAL-CASE.json",
  "package_name": "ca.on.health.idms.agreementmvp",
  "date": "2025-12-18",
  "meta": {
    "source": "#28164f81e9ab9d3da59299fa7f837eb7",
    "versionId": "1",
    "lastUpdated": "2025-12-18T14:45:11.613+00:00"
  },
  "publisher": "IDMS",
  "content": "complete",
  "property": [ {
    "uri": "http://hl7.org/fhir/concept-properties#inactive",
    "code": "inactive",
    "type": "boolean"
  } ],
  "name": "OFISPECIALCASE",
  "type": null,
  "experimental": null,
  "resourceType": "CodeSystem",
  "title": "OFI Special Case",
  "package_version": "3.0.3",
  "status": "active",
  "id": "e2139cd9-f1ca-4592-96ea-4df6a41ecfc9",
  "kind": null,
  "url": "https://health.gov.on.ca/idms/fhir/CodeSystem/OFI-SPECIAL-CASE",
  "concept": [ {
    "code": "AQUEOUS",
    "display": "Aqueous solutions or non-aqueous oral solutions (i.e., alcohol co-solvent solutions)"
  }, {
    "code": "METERED",
    "display": "Metered dose inhalers and Special Delivery Devices"
  }, {
    "code": "NON_AQUEOUS_OTIC",
    "display": "Non-aqueous ophthalmic, otic and nasal preparations"
  }, {
    "code": "SUSPENSION",
    "display": "Suspensions, emulsions or oil-based solutions"
  }, {
    "code": "NON_SYSTEMIC",
    "display": "Non-Systemic effect drug products"
  } ],
  "version": "1"
}